In Q4 2025, Oddity Tech generated $152726000 in net revenue, up 24% year-over-year, with net income of $5884000 and adjusted EBITDA of $12514000, while gross margin declined to 70.5% and adjusted EBITDA margin contracted to 8.2%.

Oddity Tech delivered a robust Q3 2025, beating expectations on revenue, adjusted EBITDA, and adjusted EPS. Net income remained flat year-over-year, but gross margin expanded. The quarter also featured the official launch of METHODIQ, their new medical brand.

Oddity Tech delivered a record-breaking Q2 2025, beating guidance across all metrics. Strong performance in online sales and upcoming brand launches contributed to optimism as the company raised its full-year forecast.

ODDITY Tech delivered an outstanding first quarter in 2025, with net revenue increasing by 27% year-over-year to $268 million and adjusted EBITDA reaching $52 million. The company also generated strong free cash flow of $87 million and maintained a robust balance sheet with $257 million in cash and investments.

ODDITY Tech Ltd. announced record-breaking financial results for the fourth quarter and full year ended December 31, 2024, exceeding financial guidance across all metrics. The company achieved significant year-over-year growth in net revenue, adjusted EBITDA, and net income, driven by strong performance in its direct-to-consumer model and continued investments in new technologies and brands.